EpiDiff

syn12207422

Created By Mette Peters Mette

phase: I
grants: U01MH103392
tissue: dorsolateral prefrontal cortex
methods: syn12207447
species: Human
dataTypes: Chromatin Activity
diagnosis: Schizophrenia
studyType: Individual
relatedStudies: syn4566010 syn12080241
studyDescription: The EpiDiff study compares frontal lobe epigenetic variation – specifically histone modifications characterized by promoter and enhancer marks – in individuals diagnosed with schizophrenia and in neurotypical controls. The resulting epigenetic maps provide a basis for investigating the relationship between regulatory histone modification landscapes and genetic risk factors for schizophrenia.
nucleicAcidSource: bulk nuclei
numberOfIndividuals: 327
contributingInstitution: Icahn School of Medicine at Mt.Sinai
syn25710588

EpiDiff page is loading…